Heterocyclic derivatives as PI3K inhibitors
US11078204B2 · kind B2 · utility
1Cited by
3References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2019 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Nov 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.